PET Results, Treatment, and Follow-up Data
Patient no. | Sex | Age (y) | Tumor and node stage | PSR* | SUV | T/N | Therapy | Follow-up | ||
---|---|---|---|---|---|---|---|---|---|---|
Finding | Months | |||||||||
1 | M | 60 | T4 N0 | 4.16 | 7.34 | 9.09 | OP + RT | NED | 32 | |
2 | M | 43 | T3 N0 | 2.40 | 4.60 | 5.81 | OP + RT | NED | 73 | |
3 | M | 67 | T2 N0 | 2.16 | 4.46 | 4.73 | RT | DOD | 9 | |
4 | M | 81 | T3 N2 | 2.32 | 5.43 | 4.88 | OP + RT | DOD | 32 | |
5 | M | 69 | T1 M0 | 1.14 | 2.43 | 2.42 | RT | NED | 35 | |
6 | M | 76 | T2 N0 | 1.14 | 4.22 | 4.79 | RT | DOD | 24 | |
7 | M | 55 | T1 N0 | 0.89 | 1.60 | 1.81 | RT | NED | 40 | |
8 | M | 70 | T4 N2 | NA | 3.95 | 3.73 | OP + RT | DOD | 8 | |
9 | M | 54 | T2 N0 | 1.58 | 3.55 | 4.69 | RT | REC | 8 | |
DOD | 32 | |||||||||
10 | M | 50 | T4 N2 | NA | 6.25 | 7.32 | OP + RT | NED | 46 | |
11 | M | 56 | T1 N0 | 0.72 | 1.42 | 1.69 | RT | NED | 56 | |
12 | M | 66 | T2 N0 | 0.82 | 2.29 | 4.23 | RT | NED | 69 | |
13 | F | 58 | T2 N0 | 1.35 | 4.23 | 5.40 | RT | DOD | 44 | |
14 | M | 55 | T4 N0 | 1.38 | 3.45 | 3.70 | OP + RT | DOD | 20 | |
15 | M | 54 | T2 N0 | 1.43 | 2.59 | 2.33 | RT | NED | 56 | |
16 | M | 75 | T4 N2 | NA | 6.95 | 7.20 | OP + RT | DOD | 15 | |
17 | M | 64 | T2 N0 | 1.44 | 1.85 | 3.01 | RT | NED | 70 | |
18 | M | 43 | T2 N1 | 1.51 | 2.91 | 2.20 | RT | NED | 67 | |
19 | M | 44 | T2 N0 | 1.66 | 4.07 | 3.21 | RT | REC | 8 | |
NED | 66 | |||||||||
20 | F | 52 | T4 N0 | NA | 3.87 | 4.71 | OP + RT | NED | 45 | |
21 | M | 59 | T2 N0 | 1.95 | 4.26 | 4.96 | RT | NED | 64 | |
22 | M | 63 | T2 N0 | 2.06 | 3.79 | 3.90 | RT | REC | 14 | |
DOD | 25 | |||||||||
23 | M | 68 | T2 N0 | 2.19 | 3.23 | 3.33 | RT | DOD | 40 | |
24 | M | 46 | T2 N0 | 2.28 | 4.20 | 4.67 | RT | REC | 7 | |
NED | 56 | |||||||||
25 | M | 56 | T2 N2 | 2.48 | 5.49 | 4.89 | OP + RT | NED | 65 | |
26 | M | 57 | T3 N2 | NA | 4.68 | 6.26 | OP + RT | NED | 47 | |
27 | M | 79 | T2 N0 | 2.50 | 5.21 | 4.22 | RT | DOD | 19 | |
28 | M | 63 | T3 N0 | 2.62 | 6.61 | 6.46 | OP + RT | DOD | 10 | |
29 | M | 59 | T2 N1 | 2.68 | 5.88 | 5.08 | RT | REC | 17 | |
DOD | 42 | |||||||||
30 | M | 63 | T4 N0 | 2.81 | 5.52 | 5.48 | OP + RT | NED | 42 | |
31 | M | 52 | T2 N0 | 3.14 | 5.47 | 4.48 | RT | NED | 59 | |
32 | M | 65 | T2 N0 | 3.30 | 5.21 | 4.66 | RT | REC | 12 | |
DOD | 35 | |||||||||
33 | M | 53 | T3 N0 | 3.75 | 4.82 | 4.54 | OP | NED | 33 | |
34 | M | 61 | T4 N2 | NA | 3.92 | 3.68 | OP + RT | NED | 49 |
↵* Data are nmol/mL/min.
OP + RT = surgery with postoperative radiotherapy; NED = no evidence of disease; RT = radiotherapy; DOD = dead of disease; NA = not available; REC = recurrent disease; OP = surgery of the primary site or neck dissection.